Quince Therapeutics Inc.
13F holders, Q1 2026 (March 31)40holders −27
9new positions
37sold out
1famous investor
$0.10avg. 13F price*
At the end of Q1 2026, 40 institutions reported holding Quince Therapeutics Inc. in their 13F filings, down 27 from Q4 2025. 9 opened new positions and 37 sold out. The largest holders were Woodline Partners LP ($527K), Millennium Management ($254K) and Shay Capital LLC ($180K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Quince Therapeutics Inc.
- CUSIP
- 22053A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $201K |
| Exits | 37 | $39.8M |
All 13F filers, Q4 2025 → Q1 2026: 8,356,627 shares bought and 12,934,013 shares sold, net −4,577,386 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| Woodline Partners LP | 0.00% | Add +167.8% | 5,200,000 | $527K |
| Millennium Management | 0.00% | Add +110.3% | 2,503,717 | $254K |
| Shay Capital LLC | 0.03% | New | 1,772,909 | $180K |
| Acadian Asset Management LLC | 0.00% | Add +10014.2% | 1,750,862 | $176K |
| Ieq Capital, LLC | 0.00% | Reduce -38.7% | 600,105 | $61K |
| BlackRock, Inc. | 0.00% | Add +0.3% | 473,259 | $48K |
| Vanguard Capital Management LLC | 0.00% | — | 461,477 | $47K |
| State Street Corp. | 0.00% | Add +7.5% | 248,011 | $25K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 232,326 | $23K |
| Susquehanna International Group, LLP | 0.00% | Reduce -50.0% | 172,640 | $18K |
| Simplex Trading, LLC | 0.00% | Reduce -7.8% | 154,093 | $16K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 132,661 | $13K |
| Two Sigma Investments, LP | 0.00% | Reduce -60.6% | 71,223 | $7K |
| Northern Trust Corp. | 0.00% | Reduce -37.9% | 65,931 | $7K |
| Intellectus Partners, LLC | 0.00% | No change | 53,312 | $5K |
| ADAR1 Capital Management, LLC | 0.00% | Add +16.8% | 50,100 | $5K |
| XTX Topco Ltd | 0.00% | Add +291.3% | 48,812 | $5K |
| Nordwand Advisors, LLC | 0.00% | New | 20,000 | $2K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 15,200 | $2K |
| Scharf Investments, LLC | 0.00% | Reduce -78.6% | 19,461 | $2K |
| Vanguard Global Advisers, LLC | 0.00% | — | 19,514 | $2K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -93.0% | 16,064 | $2K |
| Belvedere Trading LLC | 0.00% | New | 13,080 | $1K |
| Alpha Zero LLC | 0.00% | New | 13,000 | $1K |
| Mariner, LLC | 0.00% | New | 12,673 | $1K |
| Nixon Peabody Trust Co. | 0.00% | No change | 11,126 | $1K |
| LPL Financial LLC | 0.00% | New | 10,933 | $1K |
| Coyle Financial Counsel LLC | 0.00% | New | 10,509 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -41.5% | 8,740 | $886 |
| Morgan Stanley | 0.00% | Reduce -92.2% | 834 | $84 |
| UBS Group AG | 0.00% | Reduce -98.4% | 556 | $56 |
| Osaic Holdings, Inc. | 0.00% | Reduce -33.5% | 550 | $55 |
| JPMorgan Chase & Co. | 0.00% | No change | 469 | $48 |
| JDM Financial Group LLC | 0.00% | No change | 340 | $34 |
| Jones Financial Companies LLLP | 0.00% | No change | 133 | $12 |
| Hurley Capital, LLC | 0.00% | No change | 121 | $12 |
| Westside Investment Management, Inc. | 0.00% | No change | 75 | $8 |
| BNP Paribas Financial Markets | 0.00% | No change | 8 | $1 |
| Barclays PLC | 0.00% | No change | 4 | $0 |
| Royal Bank of Canada | 0.00% | New | 3,291 | $0 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.